Disease Associated mRNAs
- R2011 Human p53 circRNASummary: Circular RNA expressing human p53 protein
- R1080 EZ Cap™ Mouse GM-CSF mRNA (m1Ψ)Summary: Mouse GM-CSF mRNA with Cap 1 structure, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
- R1079 EZ Cap™ Mouse CD80 mRNA (m1Ψ, HA tag)Summary: Mouse CD80 mRNA with Cap 1 structure and HA tag sequence, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
- R1078 EZ Cap™ Mouse CD252(OX40L) mRNA (m1Ψ, HA tag)Summary: Mouse CD252 mRNA with Cap 1 structure and HA tag sequence, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
- R1077 EZ Cap™ Mouse CD137 mRNA (m1Ψ, HA tag)Summary: Mouse CD137 mRNA with Cap 1 structure and HA tag sequence, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
- R1076 EZ Cap™ Mouse CD86 mRNA (m1Ψ, HA tag)Summary: Mouse CD86 mRNA with Cap 1 structure and HA tag sequence, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
- R1050 EZ Cap™ Mouse IFN-α mRNA (m1ψ)Summary: Mouse IFN-α mRNA with Cap 1 structure, modified by m1ψ, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation
- R1049 EZ Cap™ Mouse IFN-γ mRNA (5mCTP, ψUTP)Summary: Mouse IFN-γ mRNA with Cap 1 structure, modified by 5mCTP and ψUTP, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation
- R1048 EZ Cap™ OVA mRNA (m1Ψ)Summary: Ovalbumin mRNA with Cap 1 structure, modified by m1Ψ, providing higher transcription efficiency, and suppressing RNA-mediated innate immune activation
- R1043 EZ Cap™ Mouse P16 mRNA (5-moUTP)Summary: Mouse p16 mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.